Culakova E - Search Results

1

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.

Khorana AA, Francis CW, Culakova E, Lyman GH. Khorana AA, et al. Among authors: culakova e. Cancer. 2005 Dec 15;104(12):2822-9. doi: 10.1002/cncr.21496. Cancer. 2005. PMID: 16284987 Free article.

2

Factors associated with the evaluation of geriatric assessment (GA) domains by oncology specialists in Mexico.

Verduzco-Aguirre HC, Bolaño-Guerra LM, Chargoy JM, Culakova E, Martinez-Said H, Beulo GQ, Mohile SG, Soto-Perez-de-Celis E. Verduzco-Aguirre HC, et al. Among authors: culakova e. Ecancermedicalscience. 2023 Aug 31;17:1597. doi: 10.3332/ecancer.2023.1597. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37799942 Free PMC article.

3

Reply to T. Kaneko et al.

Flannery M, Culakova E, Mohile S. Flannery M, et al. Among authors: culakova e. J Clin Oncol. 2023 May 10;41(14):2666-2667. doi: 10.1200/JCO.23.00248. Epub 2023 Mar 17. J Clin Oncol. 2023. PMID: 36930847 Free PMC article. No abstract available.

4

Use of antibiotics and risk of cancer.

Lyman GH, Culakova E, Griggs J. Lyman GH, et al. Among authors: culakova e. JAMA. 2004 Jun 9;291(22):2700; author reply 2700. doi: 10.1001/jama.291.22.2700-a. JAMA. 2004. PMID: 15187045 No abstract available.

5

Predictors of chemotherapy-induced neutropenia and its complications: results from a prospective nationwide registry.

Wolff D, Culakova E, Poniewierski MS, Lyman GH, Dale DC, Crawford J; Awareness of Neutropenia in Chemotherapy Study Group. Wolff D, et al. Among authors: culakova e. J Support Oncol. 2005 Nov-Dec;3(6 Suppl 4):24-5. J Support Oncol. 2005. PMID: 16355556 No abstract available.

6

Thromboembolism in hospitalized neutropenic cancer patients.

Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. Khorana AA, et al. Among authors: culakova e. J Clin Oncol. 2006 Jan 20;24(3):484-90. doi: 10.1200/JCO.2005.03.8877. J Clin Oncol. 2006. PMID: 16421425

7

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.

Shayne M, Crawford J, Dale DC, Culakova E, Lyman GH; ANC Study Group. Shayne M, et al. Among authors: culakova e. Breast Cancer Res Treat. 2006 Dec;100(3):255-62. doi: 10.1007/s10549-006-9254-4. Epub 2006 May 17. Breast Cancer Res Treat. 2006. PMID: 16705366

8

Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.

Griggs JJ, Culakova E, Sorbero ME, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH. Griggs JJ, et al. Among authors: culakova e. J Clin Oncol. 2007 Jan 20;25(3):277-84. doi: 10.1200/JCO.2006.08.3063. Epub 2006 Dec 11. J Clin Oncol. 2007. PMID: 17159190

9

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Khorana AA, et al. Among authors: culakova e. J Thromb Haemost. 2007 Mar;5(3):632-4. doi: 10.1111/j.1538-7836.2007.02374.x. J Thromb Haemost. 2007. PMID: 17319909 Free article. No abstract available.

10

Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective.

Cosler LE, Eldar-Lissai A, Culakova E, Kuderer NM, Dale D, Crawford J, Lyman GH. Cosler LE, et al. Among authors: culakova e. Pharmacoeconomics. 2007;25(4):343-51. doi: 10.2165/00019053-200725040-00006. Pharmacoeconomics. 2007. PMID: 17402806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters